Literature DB >> 25453062

Tobacco smoking interferes with GABAA receptor neuroadaptations during prolonged alcohol withdrawal.

Kelly P Cosgrove1, Reese McKay2, Irina Esterlis3, Tracy Kloczynski4, Evgenia Perkins4, Frederic Bois4, Brian Pittman5, Jack Lancaster6, David C Glahn2, Stephanie O'Malley5, Richard E Carson7, John H Krystal8.   

Abstract

Understanding the effects of tobacco smoking on neuroadaptations in GABAA receptor levels over alcohol withdrawal will provide critical insights for the treatment of comorbid alcohol and nicotine dependence. We conducted parallel studies in human subjects and nonhuman primates to investigate the differential effects of tobacco smoking and nicotine on changes in GABAA receptor availability during acute and prolonged alcohol withdrawal. We report that alcohol withdrawal with or without concurrent tobacco smoking/nicotine consumption resulted in significant and robust elevations in GABAA receptor levels over the first week of withdrawal. Over prolonged withdrawal, GABAA receptors returned to control levels in alcohol-dependent nonsmokers, but alcohol-dependent smokers had significant and sustained elevations in GABAA receptors that were associated with craving for alcohol and cigarettes. In nonhuman primates, GABAA receptor levels normalized by 1 mo of abstinence in both groups--that is, those that consumed alcohol alone or the combination of alcohol and nicotine. These data suggest that constituents in tobacco smoke other than nicotine block the recovery of GABAA receptor systems during sustained alcohol abstinence, contributing to alcohol relapse and the perpetuation of smoking.

Entities:  

Keywords:  GABAA receptors; alcohol dependence; neuroimaging; tobacco smoking; translational

Mesh:

Substances:

Year:  2014        PMID: 25453062      PMCID: PMC4273348          DOI: 10.1073/pnas.1413947111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Neurosteroids mediate pharmacological effects of ethanol: a new mechanism of ethanol action?

Authors:  A L Morrow; G C Janis; M J VanDoren; D B Matthews; H H Samson; P H Janak; K A Grant
Journal:  Alcohol Clin Exp Res       Date:  1999-12       Impact factor: 3.455

2.  Similarity and robustness of PET and SPECT binding parameters for benzodiazepine receptors.

Authors:  P Millet; C Graf; A Buck; B Walder; G Westera; C Broggini; M Arigoni; D Slosman; C Bouras; V Ibáñez
Journal:  J Cereb Blood Flow Metab       Date:  2000-11       Impact factor: 6.200

3.  Controlling the false discovery rate in behavior genetics research.

Authors:  Y Benjamini; D Drai; G Elmer; N Kafkafi; I Golani
Journal:  Behav Brain Res       Date:  2001-11-01       Impact factor: 3.332

4.  Neuroactive steroids reduce neuronal excitability by selectively enhancing tonic inhibition mediated by delta subunit-containing GABAA receptors.

Authors:  Brandon M Stell; Stephen G Brickley; C Y Tang; Mark Farrant; Istvan Mody
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-17       Impact factor: 11.205

5.  Enhanced neurosteroid potentiation of ternary GABA(A) receptors containing the delta subunit.

Authors:  Kai M Wohlfarth; Matt T Bianchi; Robert L Macdonald
Journal:  J Neurosci       Date:  2002-03-01       Impact factor: 6.167

6.  Standardized mean regional method for calculating global positron emission tomographic measurements.

Authors:  J S Perlmutter; P Herscovitch; W J Powers; P T Fox; M E Raichle
Journal:  J Cereb Blood Flow Metab       Date:  1985-09       Impact factor: 6.200

7.  1-Methyl-beta-carboline (harmane), a potent endogenous inhibitor of benzodiazepine receptor binding.

Authors:  H Rommelspacher; C Nanz; H O Borbe; K J Fehske; W E Müller; U Wollert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-10       Impact factor: 3.000

8.  Targeting tobacco in a community-based addiction recovery cohort: results from a computerized, brief, randomized intervention trial.

Authors:  Alison B Breland; Lauren Almond; Jennifer Kienzle; Steven J Ondersma; Alton Hart; Michael Weaver; Pamela Dillon; Dace Svikis
Journal:  Contemp Clin Trials       Date:  2014-04-08       Impact factor: 2.226

9.  Ethanol enhances alpha 4 beta 3 delta and alpha 6 beta 3 delta gamma-aminobutyric acid type A receptors at low concentrations known to affect humans.

Authors:  M Wallner; H J Hanchar; R W Olsen
Journal:  Proc Natl Acad Sci U S A       Date:  2003-11-18       Impact factor: 11.205

10.  Benzodiazepine antagonist Ro 15-1788: binding characteristics and interaction with drug-induced changes in dopamine turnover and cerebellar cGMP levels.

Authors:  H Möhler; W P Burkard; H H Keller; J G Richards; W Haefely
Journal:  J Neurochem       Date:  1981-09       Impact factor: 5.372

View more
  12 in total

1.  Mecamylamine treatment for alcohol dependence: a randomized controlled trial.

Authors:  Ismene L Petrakis; Elizabeth Ralevski; Ralitza Gueorguieva; Stephanie S O'Malley; Albert Arias; Kevin A Sevarino; Jane S Jane; Erin O'Brien; John H Krystal
Journal:  Addiction       Date:  2017-10-12       Impact factor: 6.526

Review 2.  How Imaging Glutamate, γ-Aminobutyric Acid, and Dopamine Can Inform the Clinical Treatment of Alcohol Dependence and Withdrawal.

Authors:  Ansel T Hillmer; Graeme F Mason; Lisa M Fucito; Stephanie S O'Malley; Kelly P Cosgrove
Journal:  Alcohol Clin Exp Res       Date:  2015-10-28       Impact factor: 3.455

Review 3.  Neuroimaging markers of glutamatergic and GABAergic systems in drug addiction: Relationships to resting-state functional connectivity.

Authors:  Scott J Moeller; Edythe D London; Georg Northoff
Journal:  Neurosci Biobehav Rev       Date:  2015-12-01       Impact factor: 8.989

4.  The association between gender roles and smoking initiation among women and adolescent girls.

Authors:  Nurbanu Ozbay; Alina Shevorykin; Philip Smith; Christine E Sheffer
Journal:  J Gend Stud       Date:  2019-11-24

5.  Multimodal neuroimaging of metabotropic glutamate 5 receptors and functional connectivity in alcohol use disorder.

Authors:  Kelly Smart; Patrick D Worhunsky; Dustin Scheinost; Gustavo A Angarita; Irina Esterlis; Richard E Carson; John H Krystal; Stephanie S O'Malley; Kelly P Cosgrove; Ansel T Hillmer
Journal:  Alcohol Clin Exp Res       Date:  2022-04-21       Impact factor: 3.928

6.  Nicotine and Nicotine Abstinence Do Not Interfere with GABAA Receptor Neuroadaptations During Alcohol Abstinence.

Authors:  Ansel T Hillmer; Tracy Kloczynski; Christine M Sandiego; Brian Pittman; Jon M Anderson; David Labaree; Hong Gao; Yiyun Huang; Giuseppe Deluliis; Stephanie S O'Malley; Richard E Carson; Kelly P Cosgrove
Journal:  Alcohol Clin Exp Res       Date:  2016-03-12       Impact factor: 3.455

7.  Time for Cigarette Smoke Exposure Chambers?

Authors:  Dieter J Meyerhoff
Journal:  Alcohol Clin Exp Res       Date:  2016-03-14       Impact factor: 3.455

Review 8.  Critical needs in drug discovery for cessation of alcohol and nicotine polysubstance abuse.

Authors:  C E Van Skike; S E Maggio; A R Reynolds; E M Casey; M T Bardo; L P Dwoskin; M A Prendergast; K Nixon
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2015-11-12       Impact factor: 5.067

Review 9.  Neuroimaging of reward mechanisms in Gambling disorder: an integrative review.

Authors:  Luke Clark; Isabelle Boileau; Martin Zack
Journal:  Mol Psychiatry       Date:  2018-09-13       Impact factor: 15.992

10.  Longitudinal imaging of metabotropic glutamate 5 receptors during early and extended alcohol abstinence.

Authors:  Ansel T Hillmer; Gustavo A Angarita; Irina Esterlis; Jon Mikael Anderson; Nabeel Nabulsi; Keunpoong Lim; Jim Ropchan; Richard E Carson; John H Krystal; Stephanie S O' Malley; Kelly P Cosgrove
Journal:  Neuropsychopharmacology       Date:  2020-09-12       Impact factor: 7.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.